| Literature DB >> 19936710 |
Jeong-Doo Heo1, Jung-Hwa Oh, Kyuhong Lee, Choong Yong Kim, Chang-Woo Song, Seokjoo Yoon, Jin Soo Han, Il Je Yu.
Abstract
Many in the welding industry suffer from bronchitis, lung function changes, metal fume fever, and diseases related to respiratory damage. These phenomena are associated with welding fumes; however, the mechanism behind these findings remains to be elucidated. In this study, the lungs of cynomolgus monkeys were exposed to MMA-SS welding fumes for 229 days and allowed to recover for 153 days. After the exposure and recovery period, gene expression profiles were investigated using the Affymetrix GeneChip Human U133 plus 2.0. In total, it was confirmed that 1,116 genes were up-or downregulated (over 2-fold changes, P\0.01) for the T1 (31.4 ± 2.8 mg/m3) and T2 (62.5 ± 2.7 mg/m3) dose groups. Differentially expressed genes in the exposure and recovery groups were analyzed, based on hierarchical clustering, and were imported into Ingenuity Pathways Analysis to analyze the biological and toxicological functions. Functional analysis identified genes involved in immunological disease in both groups. Additionally, differentially expressed genes in common between monkeys and rats following welding fume exposure were compared using microarray data, and the gene expression of selected genes was verified by real-time PCR. Genes such as CHI3L1, RARRES1, and CTSB were up-regulated and genes such as CYP26B1, ID4, and NRGN were down-regulated in both monkeys and rats following welding fume exposure. This is the first comprehensive gene expression profiling conducted for welding fume exposure in monkeys, and these expressed genes are expected to be useful in helping to understand transcriptional changes in monkey lungs after welding fume exposure.Entities:
Mesh:
Substances:
Year: 2010 PMID: 19936710 PMCID: PMC2820669 DOI: 10.1007/s00204-009-0486-z
Source DB: PubMed Journal: Arch Toxicol ISSN: 0340-5761 Impact factor: 5.153
Fig. 1Light micrographs of monkey lungs after 229 days of welding fume exposure a control (×100), b T2 dose (62.5 ± 2.7 mg/m3, ×100), c Control (×400), d T2 dose (62.5 ± 2.7 mg/m3, ×400)
Fig. 2Hierarchical clustering of differentially expressed genes in monkey lungs from the welding fume exposure a and recovery b groups
Differentially expressed genes in monkey lungs from welding fume exposure group
| Gene_symbol | Gene_title | RefSeq ID | Fold change (Log 2) | |
|---|---|---|---|---|
| Exp_T1 | Exp_T2 | |||
| Up-regulated genes in the exposure group | ||||
|
| X (inactive)-specific transcript | NR_001564 | 3.28 | 8.43 |
|
| Transmembrane emp24 protein transport domain containing 6 | NM_144676 | 3.65 | 5.10 |
| | Splicing factor, arginine/serine-rich 4 | NM_005626 | 2.28 | 5.00 |
| | Full-length insert cDNA clone YR55D08 | – | 4.17 | 4.58 |
| | Unknown | – | 2.49 | 4.58 |
| | Diacylglycerol kinase, beta 90 kDa | NM_004080 | 2.36 | 4.52 |
| | Tripartite motif-containing 2 | NM_015271 | 0.38 | 4.48 |
| | Echinoderm microtubule-associated protein like 5 | NM_183387 | 3.90 | 4.35 |
| | Transcribed locus | – | 3.24 | 4.06 |
| | Chromosome 5 open reading frame 28 | NM_022483 | 4.74 | 4.05 |
| | CDNA FLJ33307 fis, clone BNGH42004076 | – | 2.91 | 4.01 |
| | CDNA clone IMAGE:5302735 | – | 3.53 | 3.89 |
| | Histone cluster 1, H2bc | NM_003526 | 4.08 | 3.80 |
| | Hypothetical protein LOC339260 | – | 1.58 | 3.65 |
| | NHS-like 1 | XM_496826 | 2.75 | 3.63 |
| | Chromosome 6 open reading frame 201 | NM_001085401 | 3.25 | 3.61 |
| | Protein inhibitor of activated STAT, 2 | NM_004671 | 1.17 | 3.58 |
| | Axin 2 (conductin, axil) | NM_004655 | 4.03 | 3.49 |
| | Chitinase 1 (chitotriosidase) | NM_003465 | 2.92 | 3.32 |
| | CDNA FLJ14313 fis, clone PLACE3000341 | – | 3.67 | 3.30 |
| Down-regulated genes in the exposure group | ||||
| | Ovostatin 2 | NM_001080502 | −6.04 | −5.85 |
| | ATP-binding cassette, sub-family A (ABC1), member 13 | NM_152701 | −3.64 | −5.77 |
| | Unknown | – | −1.89 | −5.68 |
| | G-patch domain containing 2 | NM_018040 | −0.20 | −5.04 |
| | Chromosome 20 open reading frame 19 | NM_018474 | −0.30 | −4.99 |
| | Transcribed locus | – | −0.66 | −4.95 |
| | Transmembrane protein with EGF-like and two follistatin-like domains 2 | NM_016192 | −1.05 | −4.91 |
| | Kallikrein B, plasma (Fletcher factor) 1 | NM_000892 | −0.32 | −4.30 |
| | Actinin, alpha 2 | NM_001103 | −2.90 | −4.03 |
| | Unknown | – | −2.14 | −4.01 |
| | CDNA clone IMAGE:4824424 | – | −3.11 | −3.98 |
| | Adenosine deaminase, tRNA-specific 2, TAD2 homolog ( | NM_182503 | −2.37 | −3.83 |
| | Transcribed locus | – | −1.72 | −3.75 |
| | Zinc finger protein 738 | XR_015756 | −2.76 | −3.72 |
| | SLIT and NTRK-like family, member 6 | NM_032229 | −1.83 | −3.69 |
| | Hairy/enhancer-of-split related with YRPW motif 2 | NM_012259 | −2.65 | −3.66 |
| | Six transmembrane epithelial antigen of the prostate 2 | NM_001040665 | −0.74 | −3.64 |
| | Testis expressed 12 | NM_031275 | −2.40 | −3.57 |
| | Potassium voltage-gated channel, subfamily H (eag-related), member 2 | NM_000238 | −1.92 | −3.52 |
| | Potassium channel, subfamily V, member 1 | NM_014379 | −2.57 | −3.48 |
Fold change was calculated with relative average value of 2 arrays in each group comparing to corresponding controls and values were represented with log 2
Differentially expressed genes in monkey lungs from welding fume recovery group
| Gene_symbol/probe ID | Gene_title | RefSeq ID | Fold change (Log 2) | |
|---|---|---|---|---|
| Rec_T1 | Rec_T2 | |||
| Up-regulated genes in the recovery group | ||||
| | Immunoglobulin lambda locus | – | 4.63 | 4.92 |
| | Full-length insert cDNA clone ZC19A03 | – | 5.15 | 4.64 |
| | Major histocompatibility complex, class II, DP beta 1 | NM_002121 | 4.53 | 4.60 |
| | THO complex 5 | NM_001002877 | 1.59 | 4.12 |
| | Immunoglobulin heavy constant mu | – | 2.66 | 3.94 |
| | Chromosome 6 open reading frame 12 | XM_001132906 | 4.18 | 3.88 |
| | Fibronectin type III domain containing 3A | NM_001079673 | 3.65 | 3.81 |
| | Homo sapiens, clone IMAGE:3626122 | – | 3.93 | 3.81 |
| | Mitochondrial ribosomal protein L44 | NM_022915 | 1.99 | 3.75 |
| | Chitinase 1 (chitotriosidase) | NM_003465 | 2.45 | 3.73 |
| | Dedicator of cytokinesis 7 | NM_033407 | 2.79 | 3.73 |
| | Homeobox A9 | NM_152739 | 1.55 | 3.70 |
| | CDNA clone IMAGE:5216666 | – | 2.56 | 3.65 |
| | Carnitine palmitoyltransferase 1A (liver) | NM_001031847 | 2.93 | 3.63 |
| | Threonyl-tRNA synthetase | NM_152295 | 4.09 | 3.56 |
| | Homo sapiens, similar to hypothetical gene LOC130797 | – | 3.12 | 3.51 |
| | G antigen 6 | NM_001098405 | 3.57 | 3.42 |
| | Hypothetical protein LOC731851 | XM_001131041 | 3.69 | 3.37 |
| | Janus kinase 2 (a protein tyrosine kinase) | NM_004972 | 3.40 | 3.35 |
| | Chromosome 18 open reading frame 17 | NM_153211 | 1.27 | 3.33 |
| Down-regulated genes in the recovery group | ||||
| | Regulator of G-protein signaling 4 | NM_001102445 | −3.25 | −5.20 |
| | Dipeptidyl-peptidase 10 | NM_001004360 | −1.42 | −4.64 |
| | DnaJ (Hsp40) homolog, subfamily C, member 6 | NM_014787 | −0.67 | −4.61 |
| | Neurotrophic tyrosine kinase, receptor, type 2 | NM_001007097 | −0.85 | −4.32 |
| | DnaJ (Hsp40) homolog, subfamily C, member 10 | NM_018981 | −3.90 | −4.03 |
| | Major histocompatibility complex, class II, DP alpha 1 | NM_033554 | −1.64 | −3.87 |
| | Chromosome 11 open reading frame 54 | NM_014039 | 0.08 | −3.85 |
| | Growth arrest-specific 2 like 3 | NM_174942 | −2.55 | −3.84 |
| | Homo sapiens, clone IMAGE:4293443, mRNA | – | −2.39 | −3.81 |
| | Family with sequence similarity 55, member C | NM_145037 | 0.27 | −3.62 |
| | CDNA clone IMAGE:4814437 | – | −2.92 | −3.44 |
| | Spermatogenesis-associated 22 | NM_032598 | −2.50 | −3.35 |
| | Transcribed locus | – | −3.53 | −3.33 |
| | EST from clone 114659, full insert | – | −1.86 | −3.33 |
| | Zinc finger protein 483 | NM_001007169 | −1.42 | −3.31 |
| | Rapamycin-insensitive companion of mTOR | NM_152756 | −3.59 | −3.29 |
| | Transcribed locus | – | −1.25 | −3.24 |
| | CDNA: FLJ21254 fis, clone COL01317 | – | −2.57 | −3.23 |
| | Transcribed locus | – | −3.30 | −3.21 |
| | Cytochrome P450, family 26, subfamily B, polypeptide 1 | NM_019885 | −3.06 | −3.19 |
Fold change was calculated with relative average value of two arrays in each group comparing to corresponding controls, and values were represented with log 2
Functional classification of differentially expressed genes in the welding fume exposure or recovery group
| Exposure | Recovery | ||||
|---|---|---|---|---|---|
| Functions |
| No. of genes | Functions |
| No. of genes |
| Disease and disorder | |||||
| Immunological disease | 1.24E-05–1.32E-02 | 58 | Cancer | 1.55E-05–2.06E-02 | 109 |
| Genetic disorder | 2.19E-05–1.48E-02 | 152 | Immunological disease | 3.40E-05–2.06E-02 | 41 |
| Cancer | 5.55E-05–1.41E-02 | 148 | Inflammatory disease | 2.52E-04–2.06E-02 | 45 |
| Organismal injury and abnormalities | 5.65E-05–1.35E-02 | 27 | Renal and urological disease | 2.62E-04–2.06E-02 | 10 |
| Inflammatory disease | 1.06E-04–1.48E-02 | 59 | Reproductive system disease | 3.27E-04–2.06E-02 | 45 |
| Molecular and cellular functions | |||||
| Cellular growth and proliferation | 3.82E-08–1.35E-02 | 129 | Cellular growth and proliferation | 1.84E-06–2.06E-02 | 93 |
| Cellular development | 1.20E-06–1.35E-02 | 105 | Cell cycle | 7.30E-06–2.06E-02 | 38 |
| Post-translational modification | 8.86E-06–1.38E-02 | 43 | Cell death | 1.55E-05–2.06E-02 | 74 |
| Cellular function and maintenance | 1.16E-05–1.40E-02 | 22 | Cell morphology | 2.74E-05–2.06E-02 | 58 |
| Cell cycle | 2.22E-05–1.49E-02 | 52 | Cellular development | 1.56E-04–2.06E-02 | 67 |
Top functional categories for differentially expressed genes are presented for the exposure and recovery groups. P-values were calculated by comparing the number of molecules of interest relative to the total number of occurrences of these molecules in all functional annotations stored in the Ingenuity Pathways knowledge base (Fisher’s exact test with P-value adjusted using the Benjamin–Hochberg multiple testing correction)
Top-regulated genes related to inflammation in monkey lungs
| Gene_symbol | Gene_title | RefSeq ID | Fold change (Log 2) | |||
|---|---|---|---|---|---|---|
| Exp | Rec | |||||
| T1 | T2 | T1 | T2 | |||
| Up-regulated genes | ||||||
| | Cyclophilin-40 | NM_005038 | 0.59 | 2.62 | −0.39 | −1.45 |
|
| Insulin receptor | NM_000208 | 1.90 | 2.55 | −1.22 | −0.94 |
| | Carnitine palmitoyltransferase 1A (liver) | NM_001031847 | 1.67 | 2.17 | 2.93 | 3.63 |
| | Aminolevulinate, delta-, synthase 2 | NM_000032 | 0.53 | 1.63 | −0.84 | −0.26 |
| | I-FLICE isoform 5 | NM_001127183 | 2.79 | 1.46 | 1.95 | 1.18 |
| | Cyclin-dependent kinase 2 | NM_001798 | 1.05 | 1.43 | −1.17 | −0.49 |
| | Carnitine palmitoyltransferase 1A (liver) | NM_001031847 | 0.83 | 1.39 | 0.64 | 0.74 |
| | Coagulation factor II (thrombin) receptor-like 1 | NM_005242 | 0.26 | 1.18 | −0.40 | −0.06 |
| | Phosphodiesterase 4D, cAMP-specific | NM_001104631 | −0.03 | 1.00 | −0.50 | −0.22 |
| | Insulin receptor | NM_000208 | 1.14 | 0.57 | 1.04 | 0.97 |
| Down-regulated genes | ||||||
| | Kallikrein B, plasma (Fletcher factor) 1 | NM_000892 | −0.32 | −4.30 | 0.08 | −0.57 |
| | Ataxia telangiectasia mutated | NM_000051 | −1.58 | −3.24 | −0.73 | −0.53 |
| | Recombination activating gene 1 | NM_000448 | −0.62 | −3.20 | −2.17 | −2.51 |
| | Ubiquitin associated and SH3 domain containing, A | NM_001001895 | −1.05 | −3.19 | 1.04 | −0.45 |
| | Immunoglobulin kappa constant | XM_001713938 | 0.22 | −3.13 | −1.44 | −1.48 |
| | Mitogen-activated protein kinase 13 | NM_002754 | −1.62 | −2.97 | 1.09 | 1.49 |
| | Protein tyrosine phosphatase, non-receptor type 22 | NM_012411 | −0.32 | −2.93 | −1.37 | −0.39 |
| | Mediator complex subunit 7 | NM_001100816 | −1.52 | −2.64 | 1.26 | 1.11 |
| | Immunoglobulin lambda locus | – | 2.88 | −2.37 | 0.89 | 0.57 |
| | Interferon induced with helicase C domain 1 | NM_022168 | −1.48 | −2.37 | −0.58 | −0.26 |
Fold change was calculated with a relative average value of two arrays in each group, compared with the corresponding controls
Values presented are log 2 transformed
Fig. 3Toxicological functional analysis of differentially expressed genes in the exposure and recovery groups. Interesting categories of mode of action were selected and represented. The dark blue and light blue bars in the histogram indicate the exposure and recovery groups, respectively
Commonly deregulated genes in the monkey and rat welding fume exposure groups
| Gene_symbol | Gene_title | RefSeq ID | Fold change (Log 2) | ||||
|---|---|---|---|---|---|---|---|
| Monkey | Rat | Monkey | Rata | ||||
| T1 | T2 | T1 | T2 | ||||
| Up-regulated genes | |||||||
| | Chitinase 3-like 1 (cartilage glycoprotein-39) | NM_001276 | NM_053560 | 4.24 | 2.67 | 1.02 | 1.44 |
| | GM2 ganglioside activator | NM_000405 | NM_172335 | 1.12 | 1.55 | 0.59 | 0.58 |
| | Retinoic acid receptor responder (tazarotene induced) 1 | NM_002888 | NM_001014790 | 1.81 | 1.53 | 1.50 | 2.10 |
| | Cathepsin K | NM_000396 | NM_031560 | 1.28 | 1.41 | 1.37 | 1.37 |
| | DDHD domain containing 1 | NM_030637 | NM_001033066 | 1.61 | 0.96 | 0.52 | 0.68 |
| | Cathepsin B | NM_001908 | NM_022597 | 1.03 | 0.77 | 0.57 | 0.86 |
| Down-regulated genes | |||||||
| | GRB2-related adaptor protein | NM_006613 | NM_001025749 | −2.10 | −2.69 | −0.76 | −0.54 |
| | NM_000104 | NM_012940 | −2.71 | −2.60 | −0.53 | −1.00 | |
| | Cytochrome P450, family 26, subfamily B, polypeptide 1 | NM_019885 | NM_181087 | −1.23 | −1.95 | −0.66 | −0.07 |
| | Prostaglandin F2 receptor negative regulator | NM_020440 | NM_019243 | −1.63 | −1.91 | −0.59 | −0.55 |
| | Inhibitor of DNA-binding 4, dominant negative helix-loop-helix protein | NM_001546 | NM_175582 | −1.35 | −1.65 | −1.82 | −0.97 |
| | Neurogranin (protein kinase C substrate, RC3) | NM_006176 | NM_024140 | −2.51 | −1.60 | −0.71 | −0.43 |
| | Kinase D-interacting substrate of 220 kDa | NM_020738 | NM_053795 | −1.08 | −1.55 | −0.38 | −0.49 |
| | Ankyrin 2, neuronal | NM_001148 | XM_001076082 | −2.15 | −1.40 | −1.01 | −1.16 |
| | Thymopoietin | NM_001032283 | NM_012887 | −1.31 | −1.30 | −0.39 | −0.27 |
| | Prostaglandin E receptor 4 (subtype EP4) | NM_000958 | NM_032076 | −1.42 | −1.27 | −0.44 | −0.47 |
| | Ras homolog gene family, member J | NM_020663 | NM_001008320 | −1.47 | −1.27 | −0.68 | −0.62 |
| | Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) | NM_000609 | NM_001033882 | −1.96 | −1.25 | −0.59 | −0.18 |
| | Retinol-binding protein 1, cellular | NM_002899 | NM_012733 | −1.26 | −1.21 | −0.92 | −0.84 |
| | MAM domain containing 2 | NM_153267 | XM_001078660 | −1.59 | −1.19 | −0.84 | −0.48 |
| | Spondin 1, extracellular matrix protein | NM_006108 | NM_172067 | −1.40 | −1.05 | −0.50 | −0.48 |
| | Growth hormone receptor | NM_000163 | NM_017094 | −1.20 | −1.02 | −0.86 | −1.07 |
| | FXYD domain containing ion transport regulator 1 (phospholemman) | NM_005031 | NM_031648 | −1.26 | −0.96 | −0.93 | −0.87 |
| | Hydroxyprostaglandin dehydrogenase 15-(NAD) | NM_000860 | NM_024390 | −1.31 | −0.92 | −1.05 | −1.11 |
| | Neuroblastoma, suppression of tumorigenicity 1 | NM_005380 | NM_031609 | −1.04 | −0.91 | −0.68 | −0.58 |
| | Wingless-type MMTV integration site family, member 5A | NM_003392 | NM_022631 | −1.14 | −0.91 | −0.72 | −1.02 |
| | Four and a half LIM domains 1 | NM_001449 | NM_001033926 | −1.11 | −0.87 | −0.58 | −0.56 |
| | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 | NM_002252 | NM_031778 | −1.12 | −0.73 | −0.84 | −0.56 |
| | Solute carrier family 12 (sodium/potassium/chloride transporters), member 2 | NM_001046 | NM_031798 | −1.19 | −0.69 | −0.45 | −0.35 |
| | Inositol 1,4,5-trisphosphate 3-kinase B | NM_002221 | NM_019312 | −1.09 | −0.63 | −0.86 | −0.81 |
| | SRY (sex-determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal) | NM_000346 | XM_001081628 | −1.07 | −0.62 | −1.34 | −1.18 |
| | G0/G1switch 2 | NM_015714 | NM_001009632 | −1.03 | −0.60 | −1.02 | −0.77 |
| | Insulin-like growth factor binding protein 6 | NM_002178 | NM_013104 | −1.04 | −0.55 | −0.33 | −1.04 |
| | RAB28, member RAS oncogene family | NM_001017979 | NM_053978 | −1.12 | −0.51 | −0.38 | −0.36 |
| | Glucosidase, beta (bile acid) 2 | NM_020944 | NM_020944 | −1.18 | −0.51 | −0.49 | −0.32 |
| | Hairy/enhancer-of-split related with YRPW motif 1 | NM_001040708 | XM_001057389 | −1.05 | −0.46 | −0.50 | −0.63 |
| | PDZ and LIM domain 3 | NM_014476 | NM_053650 | −1.61 | −0.41 | −0.76 | −0.80 |
| | Heterogeneous nuclear ribonucleoprotein D) | NM_001003810 | NM_001082539 | −2.76 | −0.30 | −0.59 | −0.39 |
| | Ras homolog gene family, member B | NM_004040 | NM_022542 | −1.39 | −0.12 | −0.80 | −0.61 |
Fold change was calculated with a relative average value of two (monkey model) or three arrays (rat model) in each group, compared with the corresponding controls. Values presented are log 2 transformed
aMicroarray data in the rat model were used with the permission of Oh et al. (2007). Differentially expressed genes were compared as described in the "Materials and methods". T1 dose means 31.4 ± 2.8 mg/m3 51.4 ± 2.89 mg/m3 and T2 dose means 62.5 ± 2.7 and 84.63 ± 2.87 mg/m3 in monkey and rat models, respectively
Fig. 4Verification of top-ranked genes deregulated in monkey lung after welding fume exposure. Expression patterns of selected genes detected from the microarray experiment for monkey lung were analyzed in both the T1- and T2-dosed monkey and rat lungs by real-time PCR. a Six up-regulated genes, b Six down-regulated genes in the welding fume exposure group of monkeys. Three independent rat samples were used to confirm the gene expression levels and average fold change. The standard deviation was calculated as described in the “Materials and methods” section